期刊文献+

中介素与高血压合并房颤患者心房纤维化的关系 被引量:2

Relationship Between Intermedin and Atrial Fibrosis in Patients of Hypertension Combined with Atrial Fibrillation
原文传递
导出
摘要 观察中介素(IMD)在高血压合并房颤患者的变化及与心房纤维化的关系。从2010年6月~2011年6月在四川大学华西医院心内科门诊随访的患者中,筛选出符合要求的受试者150例参加研究。其中包括单纯高血压组(50例),高血压合并阵发性房颤组(48例),高血压合并持续性房颤组(52例)。对受试者完善病史收集及体格检查,进行心脏彩超检查,酶联免疫吸附法测定血浆IMD和转化生长因子β-1(TGF-β1)水平。试验结果显示:1血浆IMD、TGF-β1、左房直径(LAD)水平在三组间比较,差异有统计学意义且分布趋势一致,均是高血压合并房颤组高于单纯高血压组,且持续性房颤组高于阵发性房颤组。2相关性研究结果显示IMD与TGF-β1呈正相关(r=0.51,P〈0.001),IMD与LAD呈正相关(r=0.59,P〈0.001),TGF-β1与LAD呈正相关(r=0.57,P〈0.001);偏回归分析显示IMD与TGF-β1呈正相关(标准系数β=0.31,P〈0.001),IMD与LAD呈正相关(标准系数β=0.40,P〈0.001),TGF-β1与LAD呈正相关(标准系数β=0.31,P〈0.001)。结果提示,随房颤进展心房结构纤维化逐渐加重,IMD可能抑制了心房肌纤维化的病理生理过程。 This study was aimed to evaluate the relationship between the changes of plasma intermedin(IMD)and atrial fibrosis in hypertensive patients with atrial fibrillation.During the period from 2010 to 2011,appropriate 150 subjects of out-patients(female 50%,male 50%)were selected in West China Hospital,Sichuan University,and were divided into three groups:the hypertension-only group,the hypertension combined with paroxysmal atrial fibrillation group and the hypertension combined with persistent atrial fibrillation group.Firstly,we collected the Physical examination results and medical history records of the patients.We then performed ultrasound cardiogram and blood biochemical tests on the patients.We also detected the plasma IMD and transforming growth factorβ1(TGF-β1)using ELISA.The results showed that compared with the hypertensive group,the plasma level of IMD,TGF-β1and left atrium director(LAD)in the hypertensive combined with atrial fibrillation group were higher significantly.Compared with the paroxymal atrial fibrillation group,the levels of IMD,TGF-β1and LAD were higher significantly in persistent atrial fibrillation group.Analysis of correlation and partial correlation showed that IMD was positively correlated with TGF-β1(r=0.51,P〈0.001),IMD was positively correlated with LAD(r=0.59,P〈0.001),and TGF-β1was positively correlated with LAD(r=0.57,P〈0.001).The results suggest that IMD might suppress the pathophysiological process of atrial fibrillation.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2014年第5期1097-1101,1110,共6页 Journal of Biomedical Engineering
关键词 中介素 心房颤动 转化生长因子Β-1 心房纤维化 intermedin atrial fibrillation transforming growth factor β1 atrial fibrosis
  • 相关文献

参考文献26

  • 1LIP G Y, TSE H F. Management of atrial fibrillation [J].Lancet, 2007,370(9587) : 604-618.
  • 2HAISSAGUERRE M,JAISP, SHAH D C,et al. Spontane-ous initiation of atrial fibrillation by ectopic beats originatingin the pulmonary veins [J]. N Engl J Med,1998,339(10):659-666.
  • 3ALLESSIE M,AUSMA J, SCHOTTEN U. Electrical, con-tractile and structural remodeling during atrial fibrillation[J]. Cardiovasc Res, 2002,54(2) ; 230-246.
  • 4BURSTEIN B,NATTE1 S. Atrial fibrosis: mechanisms andclinical relevance in atrial fibrillation [J]. J Am Coll Cardiol.2008, 51(8): 802-809.
  • 5ECKSTEIN J, VERHEULE S, DE GROOT N M, et al.Mechanisms of perpetuation of atrial fibrillation in chronicallydilated atria [J], Prog Biophys Mol Biol. 2008,97 ( 2-3 ):435-451.
  • 6LIJNEN P J,PETROV V V,FAGARD R H. Induction ofcardiac fibrosis by transforming growth factor-beta ( 1 ) [J].Mol Genet Metab,2000,71(1-2) : 418-435.
  • 7ROH J,CHANG C L, BHALLA A, et al. Intermedin is acalcitonin/calcitonin gene-related peptide family peptide actingthrough the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes [J], J Biol Chem,2004, 279(8): 7264-7274.
  • 8TAKEI Y,INOUE K, OGOSHI M, et al. Identification ofnovel adrenomedulIin in mammals: a potent cardiovascularand renal regulator [J]. FEBS Lett, 2004. 556(1-3) : 53-58.
  • 9KINDT F, WIEGAND S,LOSER C, et al. Intermedin: askin peptide that is downregulated in atopic dermatitis [J]. JInvest Dermatol, 2007,127(3) : 605-613.
  • 10MORIMOTO R, SATOH F,MURAKAMI O,et al. Ex-pression of adrenomedullin2/intermedin in human brain,heart. and kidney [J]. Peptides, 2007,28(5) : 1095-1103.

同被引文献33

  • 1Rahman F, Kwan GF, Benjamin EJ. Global epidemiology ofatrial fibrillation. Nat Rev Cardiol,2014,11 : 639 -654.
  • 2Benjamin EJ, Wolf PA, DAgostino RB, et al. Impact of at-rial fibrillation on the risk of death : the Framingham HeartStudy. Circulation,1998,98 : 946 -952.
  • 3Latini R, Masson S, Pirelli S, et al. Circulating cardiovas-cular biomarkers in recurrent atrial fibrillation : data from theGISSI-atrial fibrillation trial. J Intern Med,2011,269 :160-171.
  • 4Pizon M, Friedel N, Pizon M, et al. Impact of epicardialablation of concomitant atrial fibrillation on atrial natriureticpeptide levels and atrial function in 6 months follow-up : doespreoperative ANP level predict outcome of ablation. J Car-diothorac Surg,2013,8 : 218.
  • 5Fan J, Cao H,Su L, et al. NT-proBNP, but not ANP andC-reactive protein, is predictive of paroxysmal atrial fibrilla-tion in patients undergoing pulmonary vein isolation. J IntervCard Electrophysiol, 2012,33 : 93 -100.
  • 6Hijazi Z, Oldgren J, Andersson U, et al. Cardiac biomark-ers are associated with an increased risk of stroke and deathin patients with atrial fibrillation : a Randomized Evaluationof Long-term Anticoagulation Therapy ( RE-LY) substudy.Circulation ,2012,125 : 1605 - 1616.
  • 7Psychari SN, Chatzopoulos D, Iliodromitis EK, et al. C-re-active protein, interleukin 6, and N-terminal pro-brain natri-uretic peptide following cardioversion of atrial fibrillation : isthere a role of biomarkers in arrhythmia recurrence. Angiolo-gy,2011,62 : 310 -316.
  • 8January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fi-brillation :executive summary. J Am Coll Cardiol,2014,64: el -76.
  • 9Wang H, Liu J, Fang P, et al. Big endothelin-1 as a pre-dictor of atrial fibrillation recurrence after primary ablationonly in patients with paroxysmal atrial fibrillation. Herz,2012,37 : 919 -925.
  • 10Falcone C, Buzzi MP, D^Angelo A, et al. Apelin plasmalevels predict arrhythmia recurrence in patients with persis-tent atrial fibrillation. Int J Immunopathol Pharmacol,2010,23 : 917 -925.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部